JPMorgan raises Biogen price target after Q3 revenue hit $2.8 billion

Statements (5)

1. ▲ Bullish

   Biogen reported third-quarter revenue that exceeded expectations.

   investors.comOct 28, 2026 10:10 UTCHigh importance
2. ▲ Bullish

   Biogen's CEO stated the company has returned to growth.

   investors.comOct 28, 2026 10:10 UTCHigh importance
3. ▲ Bullish

   Biogen's third-quarter revenue exceeded expectations.

   investors.comOct 28, 2026 10:10 UTCHigh importance
4. ▲ Bullish

   Biogen's revenue rose 11% to $2.8 billion in the third quarter of fiscal 2026

   breakingthenews.netOct 28, 2026 10:02 UTC
5. ▼ Bearish

   Biogen reported earnings that crushed analyst estimates

   barrons.comOct 28, 2026 10:01 UTCHigh importance